During the processes of mitochondrial fission and fusion, proteins such as DRP1, MFN1, and MFN2 act to enhance the effectiveness of chemotherapy by inhibiting the metabolic pathways and proliferation of tumor cells (87). Here, DNM1L is linked to neoplasm.